H uman experimentation (such as in regard to pharmaceutical efficacy, medical equipment, medical technology, and medical methods) aims to promote the continuous development and application of medical technology so as to improve the human condition. 1Human experimentation involves the interplay of rights and obligations among the sponsor, researcher, and research subjects.In this context, the sponsor is the person or organization that initiates, funds, and supervises the human trials, assuming corresponding responsibilities; the researcher is the physician or scientist who conducts the medical tests; and research subjects are the natural persons who participate in the trials.With the continuous improvement of medical technology in China in recent years, legal issues connected with human experimentation have become increasingly prominent.In August 2012, the American Journal of Clinical Nutrition published a paper titled ''b-Carotene in Golden Rice is as good as b-carotene in oil at providing vitamin A to children.''The paper detailed that research groups from Tufts University, the Chinese Center for Disease Control and Prevention, and other scientific research institutions selected 72 healthy 6-8 year-old children in Hunan, China; divided them into three groups; and provided 24 children with 60 g of Golden Rice for 21 days while drawing their blood to measure the vitamin A concentrations.The results showed that the effect of the Golden Rice was as good as that of vitamin A capsules. 2 This experiment, known as the ''Golden Rice event,'' aroused strong feelings and led to vigorous discussion in China.This paper discusses the operation of (and problems with) China's current legal system in regard to human experimentation in the context of this event.I.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2014) studied this question.